The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $82.07

Today's change+0.15 +0.18%
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.
 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $82.07

Today's change+0.15 +0.18%
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.

Cardinal Health Inc up (U.S.)$0.15

Cardinal Health Inc closed up Wednesday by (U.S.)$0.15 or 0.18% to (U.S.)$82.07. Over the last five days, shares have gained 1.76% and are currently 1.59% off of the 52-week high. Shares have outperformed the S&P 500 by 8.72% during the last year.

Key company metrics

  • Open(U.S.) $82.11
  • Previous close(U.S.) $81.92
  • High(U.S.) $82.59
  • Low(U.S.) $81.85
  • Bid / Ask-- / --
  • YTD % change+22.84%
  • Volume481,746
  • Average volume (10-day)1,522,492
  • Average volume (1-month)1,431,588
  • Average volume (3-month)1,888,619
  • 52-week range(U.S.) $63.06 to (U.S.) $83.40
  • Beta0.53
  • Trailing P/E25.88×
  • P/E 1 year forward19.28×
  • Forward PEG1.56×
  • Indicated annual dividend(U.S.) $1.37
  • Dividend yield1.67%
  • Trailing EPS(U.S.) $3.17
Updated December 24 1:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.20%

Based on its net profit margin of 1.20%, Cardinal Health Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue24,07022,89421,42722,240
Total other revenue--------
Total revenue24,07022,89421,42722,240
Gross profit1,3411,2561,2971,345
Total cost of revenue22,72921,63820,13020,895
Total operating expense23,60422,50720,91921,721
Selling / general / administrative775779699729
Research & development--------
Depreciation / amortization53635656
Interest expense (income), net operating--------
Unusual expense (income)47273441
Other operating expenses, total--------
Operating income466387508519
Interest income (expense), net non-operating-34-33-34-33
Gain (loss) on sale of assets--------
Other--------
Income before tax435357507492
Income after tax266234315275
Income tax, total169123192217
Net income266234315278
Total adjustments to net income--------
Net income before extra. items266234315275
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items266234315275
Inc. avail. to common incl. extra. items266234315278
Diluted net income266234316278
Dilution adjustment----1--
Diluted weighted average shares340342347346
Diluted EPS excluding extraordinary itemsvalue per share0.780.680.910.79
Dividends per sharevalue per share0.340.350.300.30
Diluted normalized EPSvalue per share0.870.740.970.86